Eris Lifesciences (NSE:ERIS) Total Assets : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Total Assets?

Eris Lifesciences's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil.

Warning Sign:

If a company builds assets at 20.7% a year, faster than its revenue growth rate of 14.2% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Eris Lifesciences's average Total Assets Growth Rate was 31.60% per year. During the past 3 years, the average Total Assets Growth Rate was 35.10% per year. During the past 5 years, the average Total Assets Growth Rate was 20.70% per year. During the past 10 years, the average Total Assets Growth Rate was 37.90% per year.

During the past 11 years, Eris Lifesciences's highest 3-Year average Total Assets Growth Rate was 68.70%. The lowest was 8.70%. And the median was 38.50%.

Total Assets is connected with ROA %. Eris Lifesciences's annualized ROA % for the quarter that ended in Dec. 2023 was 10.60%. Total Assets is also linked to Revenue through Asset Turnover. Eris Lifesciences's Asset Turnover for the quarter that ended in Dec. 2023 was 0.12.

Eris Lifesciences Total Assets Historical Data

The historical data trend for Eris Lifesciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Total Assets Chart

Eris Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

15,536.62

15,523.05

18,347.80

22,721.39

36,673.28

Eris Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															-	36,673.28	-	38,751.88	-

Eris Lifesciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Eris Lifesciences's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	22206.77	+	14466.51
	=	36,673

Eris Lifesciences's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	N/A	+	N/A
	=	N/A

Eris Lifesciences (NSE:ERIS) Total Assets Explanation

Total Assets is connected with ROA %.

Eris Lifesciences's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	4109.44	/	( (38751.88	+	0)	/ 1 )
	=	4109.44	/	38751.88
	=	10.60 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Eris Lifesciences's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	4834.81	/	( (38751.88	+	0)	/ 1 )
=	4834.81	/	38751.88
=	0.12

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Eris Lifesciences Total Assets Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (NSE:ERIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (NSE:ERIS) » Definitions » Total Assets

Traded in Other Exchanges

540596:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (NSE:ERIS) Headlines

No Headlines